» Articles » PMID: 37591930

CFLIP Regulates Alternative NLRP3 Inflammasome Activation in Human Monocytes

Overview
Date 2023 Aug 17
PMID 37591930
Authors
Affiliations
Soon will be listed here.
Abstract

The innate immune responses, including inflammasome activation, are paramount for host defense against pathogen infection. In contrast to canonical and noncanonical inflammasome activation, in this study, heat-killed gram-negative bacteria (HK bacteria) were identified as single-step stimulators of the NLRP3 inflammasome in human monocytes, and they caused a moderate amount of IL-1β to be released from cells. Time course experiments showed that this alternative inflammasome response was finished within a few hours. Further analysis showed that the intrinsically limited NLRP3 inflammasome activation response was due to the negative regulation of caspase-8 by the short isoform of cFLIP (cFLIPs), which was activated by NF-κB. In contrast, overexpressed cFLIP, but not overexpressed cFLIP, inhibited the activation of caspase-8 and the release of IL-1β in response to HK bacteria infection in human monocytes. Furthermore, we demonstrated that TAK1 activity mediated the expression of cFLIPs and was upstream and essential for the caspase-8 cleavage induced by HK bacteria in human monocytes. The functional specificity of cFLIPs and TAK1 revealed unique responses of human monocytes to a noninvasive pathogen, providing novel insights into an alternative regulatory pathway of NLRP3 inflammasome activation.

Citing Articles

Raptinal: a powerful tool for rapid induction of apoptotic cell death.

Smith A, Hergenrother P Cell Death Discov. 2024; 10(1):371.

PMID: 39164225 PMC: 11335860. DOI: 10.1038/s41420-024-02120-1.


GSNOR negatively regulates the NLRP3 inflammasome via S-nitrosation of MAPK14.

Liu Q, Jiao L, Ye M, Ma Z, Yu J, Su L Cell Mol Immunol. 2024; 21(6):561-574.

PMID: 38570588 PMC: 11143353. DOI: 10.1038/s41423-024-01155-9.


New Insights on NLRP3 Inflammasome: Mechanisms of Activation, Inhibition, and Epigenetic Regulation.

Kodi T, Sankhe R, Gopinathan A, Nandakumar K, Kishore A J Neuroimmune Pharmacol. 2024; 19(1):7.

PMID: 38421496 PMC: 10904444. DOI: 10.1007/s11481-024-10101-5.


Role for Caspase-8 in the Release of IL-1β and Active Caspase-1 from Viable Human Monocytes during Toxoplasma gondii Infection.

Pandori W, Matsuno S, Shin J, Kim S, Kao T, Mallya S J Immunol. 2024; 212(7):1161-1171.

PMID: 38372637 PMC: 11410338. DOI: 10.4049/jimmunol.2200513.

References
1.
Ajibade A, Wang H, Wang R . Cell type-specific function of TAK1 in innate immune signaling. Trends Immunol. 2013; 34(7):307-16. DOI: 10.1016/j.it.2013.03.007. View

2.
Thornberry N, Bull H, Calaycay J, Chapman K, Howard A, Kostura M . A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature. 1992; 356(6372):768-74. DOI: 10.1038/356768a0. View

3.
Safa A, Pollok K . Targeting the Anti-Apoptotic Protein c-FLIP for Cancer Therapy. Cancers (Basel). 2012; 3(2):1639-71. PMC: 3281420. DOI: 10.3390/cancers3021639. View

4.
Chang D, Xing Z, Pan Y, Algeciras-Schimnich A, Barnhart B, Yaish-Ohad S . c-FLIP(L) is a dual function regulator for caspase-8 activation and CD95-mediated apoptosis. EMBO J. 2002; 21(14):3704-14. PMC: 125398. DOI: 10.1093/emboj/cdf356. View

5.
Xia S, Zhang Z, Magupalli V, Pablo J, Dong Y, Vora S . Gasdermin D pore structure reveals preferential release of mature interleukin-1. Nature. 2021; 593(7860):607-611. PMC: 8588876. DOI: 10.1038/s41586-021-03478-3. View